Arcus Biosciences, Inc.
RCUS· NYSE
Released Aug 6, 2020, after the close
10-Q filed Aug 6, 2020, 37 days after period end · 0001564590-20-037782
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $1.75M | $1.75M | $1.25M | — |
| Net Income | -$45.07M | -$28.09M | -$13.53M | -$9.55M |
| EPS Diluted |
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
| -$0.93 |
| -$0.64 |
| -$0.32 |
| -$5.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.